Thyroid Disorder in Systemic Lupus Erythematosus Patients in Southeast Iran

Z Zakeri; M Sandooghi

Outlines

Abstract
References
Copyright

Thyroid Disorder in Systemic Lupus Erythematosus Patients in Southeast Iran

Author(s):

Z Zakeri¹,

M Sandooghi^1,*

1Assistant Professor, Department of Internal Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

Shiraz E-Medical Journal:Vol. 11, issue 1; e93798

Published online:Jan 01, 2010

Article type:Research Article

Received:May 15, 2019

Accepted:Nov 03, 2009

How to Cite:Z ZakeriM SandooghiThyroid Disorder in Systemic Lupus Erythematosus Patients in Southeast Iran.Shiraz E-Med J.11(1):e93798.

Abstract

Background: We conducted this study to clarify the prevalence of thyroid dysfunction in
patients with Systemic Lupus Erythematosus (SLE) and compared it to a matched healthy
controls group.

Material and methods: Eighty-three SLE and 166 matched healthy controls underwent clinical
examination and laboratory evaluation for serum T3, T4, TSH and Thyroid peroxides antibody
(TPO AB).

Results: 24.1% of SLE patients and 13.3% of control group had thyroid dysfunction (p value
= 0.04). Clinical thyroid dysfunction was seen neither in SLE patients nor in the control
group. Elevated TSH levels were the most common dysfunction (19.3%) of the SLE, compared
with control group (5.4%). Positive TPO antibody was detected in 16.9% of SLE and
16.3% of the control group. Mean level of TPO antibody was higher in SLE patients with
thyroid dysfunction (137.05) than SLE patients without the disorder (30.8) (p value=0.007).

Conclusion: We concluded thyroid dysfunction was more frequent in SLE patients than in
healthy controls. Moreover, SLE patients with anti TPO were more likely to have thyroid
dysfunction than the control group.

Keywords

Fulltext

This part is available in the PDF file.

References

1.
The references are available in the PDF file.

comments